Protectivity and safety following recombinant hepatitis B vaccine with different source of bulk compared to hepatitis B (Bio Farma) vaccine in Indonesia

PURPOSE: Indonesia, a high populous and the second-highest country in epidemicity of hepatitis B in South-East Asia require maintaining its capacity of monovalent hepatitis B production to keep up with both the national immunization program and global needs. To keep the sustainability of the vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Nency, Yetty M., Rahmadi, Farid Agung, Mulyono, Anantyo, Dimas Tri, Farhanah, Nur, Hapsari, Rebriarina, Farida, Helmia, Sadhana, Udadi, Djagat, Herry, Kristina, Tri Nur, Juniarto, Achmad Zulfa, Puspita, Mita, Sari, Rini Mulia, Bachtiar, Novilia Sjafri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844670/
https://www.ncbi.nlm.nih.gov/pubmed/35223664
http://dx.doi.org/10.7774/cevr.2022.11.1.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844670/
https://www.ncbi.nlm.nih.gov/pubmed/35223664
http://dx.doi.org/10.7774/cevr.2022.11.1.43

Ejemplares similares